Clinical Trial Update: Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating durvalumab in combination with chemotherapy as first-line treatment for advanced biliary tract cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Durvalumab (durvalumab)

Snippet

Sponsor: AstraZeneca | Conditions: Biliary Tract Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING